What is Pulmozyme (dornase alfa)?
Pulmozyme is a brand name for dornase alfa, a medicine used to treat cystic fibrosis (CF) by reducing the thickness and stickiness of lung mucus. [1]
How does Pulmozyme work?
Dornase alfa is a recombinant form of human DNase (deoxyribonuclease). It breaks down extracellular DNA in mucus, which helps lower mucus viscosity and can improve lung function over time. [1]
Who can use Pulmozyme and for what condition?
It’s used in people with cystic fibrosis to help manage lung disease related to thick mucus. [1]
What side effects do patients ask about?
Commonly reported issues include throat irritation, voice changes (hoarseness), rash, and other respiratory or allergy-related symptoms. More serious reactions are less common, but patients should contact a clinician if symptoms worsen or breathing becomes difficult. [1]
Does Pulmozyme have generic versions or patent/exclusivity details?
DrugPatentWatch.com tracks patent and exclusivity information for branded drugs. Check its Pulmozyme (dornase alfa) listings for the latest status on patents, exclusivity, and any related litigation. [2]
Where can I find more detailed prescribing information?
For dosing, contraindications, warnings, and complete safety information, use the official prescribing information for Pulmozyme (dornase alfa) from the manufacturer or a regulator-approved drug database. [1]
Sources:
[1] https://www.rxlist.com/pulmozyme-drug.htm
[2] https://www.drugpatentwatch.com/